| |
| |
|
| Insider
Information: |
Coleman Mark |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
25,097 |
|
|
Indirect Shares
|
403,856 |
|
|
| Direct
Value |
$1,819,533 |
|
|
|
Indirect Value
|
$29,279,560 |
|
|
| Total
Shares |
428,953 |
|
|
| Total
Value |
$31,099,093 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -33.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Axsome Therapeutics, Inc. |
AXSM |
Director |
2023-09-15 |
25,097 |
2023-09-15 |
403,856 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2023-09-15 |
4 |
AS |
$75.18 |
$1,396,189 |
I/I |
(18,572) |
403,856 |
0 |
% |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2023-09-15 |
4 |
AS |
$75.19 |
$828,241 |
D/D |
(11,016) |
25,097 |
0 |
% |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2023-09-15 |
4 |
OE |
$3.67 |
$40,429 |
D/D |
11,016 |
36,113 |
0 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2023-01-03 |
4 |
OE |
$1.30 |
$22,751 |
D/D |
17,501 |
25,097 |
0 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2022-03-15 |
4 |
OE |
$1.30 |
$4,545 |
D/D |
3,496 |
7,596 |
0 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2021-05-12 |
4 |
B |
$58.15 |
$29,075 |
I/I |
500 |
420,998 |
2.1 |
% |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2020-08-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
397,998 |
397,998 |
0 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2020-08-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
397,998 |
5,700 |
0 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2020-06-29 |
4 |
B |
$78.50 |
$51,025 |
D/D |
650 |
403,698 |
2.39 |
% |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2019-06-26 |
4 |
B |
$23.10 |
$364,980 |
D/D |
15,800 |
668,848 |
2.39 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2019-06-25 |
4 |
B |
$23.25 |
$9,300 |
D/D |
400 |
653,048 |
2.39 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2019-05-13 |
4 |
B |
$21.44 |
$99,696 |
D/D |
4,650 |
652,648 |
2.39 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2019-03-19 |
4 |
B |
$12.18 |
$62,118 |
I/I |
5,100 |
5,100 |
2.1 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2015-11-24 |
4 |
OE |
$5.40 |
$3,224,166 |
D/D |
564,948 |
647,998 |
0 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2015-11-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
83,050 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
